164 related articles for article (PubMed ID: 10677095)
1. Expression of p53 in arsenic-related and sporadic basal cell carcinoma.
Boonchai W; Walsh M; Cummings M; Chenevix-Trench G
Arch Dermatol; 2000 Feb; 136(2):195-8. PubMed ID: 10677095
[TBL] [Abstract][Full Text] [Related]
2. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma.
Gailani MR; Leffell DJ; Ziegler A; Gross EG; Brash DE; Bale AE
J Natl Cancer Inst; 1996 Mar; 88(6):349-54. PubMed ID: 8609643
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinoma in chronic arsenicism occurring in Queensland, Australia, after ingestion of an asthma medication.
Boonchai W; Green A; Ng J; Dicker A; Chenevix-Trench G
J Am Acad Dermatol; 2000 Oct; 43(4):664-9. PubMed ID: 11004623
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
[TBL] [Abstract][Full Text] [Related]
6. Frequent p53 accumulation in the chronically sun-exposed epidermis and clonal expansion of p53 mutant cells in the epidermis adjacent to basal cell carcinoma.
Urano Y; Asano T; Yoshimoto K; Iwahana H; Kubo Y; Kato S; Sasaki S; Takeuchi N; Uchida N; Nakanishi H
J Invest Dermatol; 1995 Jun; 104(6):928-32. PubMed ID: 7769260
[TBL] [Abstract][Full Text] [Related]
7. Carcinogen-specific mutation pattern in the p53 tumour suppressor gene in UV radiation-induced basal cell carcinoma.
Weihrauch M; Bader M; Lehnert G; Wittekind C; Tannapfel A; Wrbitzky R
Int Arch Occup Environ Health; 2002 Apr; 75(4):272-6. PubMed ID: 11981662
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
Reifenberger J; Wolter M; Knobbe CB; Köhler B; Schönicke A; Scharwächter C; Kumar K; Blaschke B; Ruzicka T; Reifenberger G
Br J Dermatol; 2005 Jan; 152(1):43-51. PubMed ID: 15656799
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p53 protein in basal cell carcinomas of human skin.
Shea CR; McNutt NS; Volkenandt M; Lugo J; Prioleau PG; Albino AP
Am J Pathol; 1992 Jul; 141(1):25-9. PubMed ID: 1632467
[TBL] [Abstract][Full Text] [Related]
10. Infrequent p53 mutations in arsenic-related skin lesions.
Castrén K; Ranki A; Welsh JA; Vähäkangas KH
Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis.
Kubo Y; Urano Y; Yoshimoto K; Iwahana H; Fukuhara K; Arase S; Itakura M
J Invest Dermatol; 1994 Apr; 102(4):440-4. PubMed ID: 8151121
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
13. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.
Maurer TA; Christian KV; Kerschmann RL; Berzin B; Palefsky JM; Payne D; Tyring SK; Berger TG
Arch Dermatol; 1997 May; 133(5):577-83. PubMed ID: 9158410
[TBL] [Abstract][Full Text] [Related]
15. UV-specific p53 and PTCH mutations in sporadic basal cell carcinoma of sun-exposed skin.
Ratner D; Peacocke M; Zhang H; Ping XL; Tsou HC
J Am Acad Dermatol; 2001 Feb; 44(2):293-7. PubMed ID: 11174390
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias.
Kim MY; Park HJ; Baek SC; Byun DG; Houh D
J Dermatol Sci; 2002 May; 29(1):1-9. PubMed ID: 12007715
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy-induced basal cell carcinomas of the scalp: are they genetically different?
Tessone A; Amariglio N; Weissman O; Jacob-Hirsch J; Liran A; Stavrou D; Haik J; Orenstein A; Winkler E
Aesthetic Plast Surg; 2012 Dec; 36(6):1387-92. PubMed ID: 23052377
[TBL] [Abstract][Full Text] [Related]
18. Characterization of p53 gene mutations in basal-cell carcinomas: comparison between sun-exposed and less-exposed skin areas.
Matsumura Y; Nishigori C; Yagi T; Imamura S; Takebe H
Int J Cancer; 1996 Mar; 65(6):778-80. PubMed ID: 8631591
[TBL] [Abstract][Full Text] [Related]
19. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
[TBL] [Abstract][Full Text] [Related]
20. Silencing of the cell cycle checkpoint gene 14-3-3σ in basal cell carcinomas correlates with reduced expression of IKK-α.
Molin SC; Grgic M; Ruzicka T; Herzinger T
J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1113-6. PubMed ID: 24219383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
